Wolters Kluwer, Health announced today a partnership with Zhejiang University to publish the journal Infectious Microbes & Diseases (IMD) under the Lippincott portfolio …… to accelerate the dissemination, exchange and utilization of scientific research results related to the field of infectious microbes and infectious diseases. The open access journal provides a forum where researchers, clinicians and policymakers can exchange ideas and learn about significant advances in the field.
Wolters Kluwer partners with Zhejiang University to Publish Infectious Microbes & Diseases Journal
Through use of the open-access model, IMD seeks to contribute globally to the translation of basic research findings and evaluation of current and novel treatments into the promotion of optimal practices for diagnosis and treatment of infections to improve public health. It will publish research articles, review articles, case reports, comments and editorials from all fields related to infectious microbes and diseases, including basic research of infectious diseases, pathogens and medical microbiology, host-microbe interactions and epidemiology of infectious diseases.
“We are excited to be working with Zhejiang University on the creation of IMD as a way to accelerate the dissemination of research findings and promote their integration in to best practices to guide the diagnosis and treatment of infections,” said Jayne Marks, Vice President, Global Publishing, Wolters Kluwer, Health Learning, Research and Practice. “As a provider of healthcare solutions, one of our top goals is to bring important research to the medical field in every area of the globe to help ensure patients receive the highest quality care for optimal outcomes. Infectious Microbes & Diseases is an important contributor toward that goal.”
“An international journal dedicated to infectious disease is needed now more than ever before,” said Prof. Min Zheng, Vice President, Zhejiang University First Affiliated Hospital. “By partnering with Wolters Kluwer, we are able to leverage its international reach to help bring Infectious Microbes & Diseases to researchers, policymakers and clinicians worldwide with the power to influence practice improvements that will ultimately increase the quality and safety of patient care.”
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the health, tax & accounting, governance, risk & compliance, and legal & regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.